The mpox outbreak – characterised by the all-too-familiar lack of vaccines for Africa – provided added impetus to the global negotiations for a...
Vous n'êtes pas connecté
GENEVA, Switzerland – The World Health Organization (WHO) has asked manufacturers of mpox in vitro diagnostics (IVDs) to submit an expression of interest for Emergency Use Listing (EUL), in ongoing discussions with manufacturers about the need for effective diagnostics, particularly in low-income settings. The request for EUL expressions of interest by manufacturers is the latest development in […]
The mpox outbreak – characterised by the all-too-familiar lack of vaccines for Africa – provided added impetus to the global negotiations for a...
This content is for members only. Visit the site and log in/register to read.
This content is for members only. Visit the site and log in/register to read.
This content is for members only. Visit the site and log in/register to read.
This content is for members only. Visit the site and log in/register to read.
This content is for members only. Visit the site and log in/register to read.
This content is for members only. Visit the site and log in/register to read.
GENEVA: Limited capacity is keeping Mpox testing coverage low in the DR Congo – the epicentre of the international emergency – the World Health...
This content is for members only. Visit the site and log in/register to read.
In coordination with Member States, the World Health Organization (WHO) and partners have established an access and allocation mechanism for mpox...